OpenURL Connection Search

Select item for more details and to access through your institution.

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
Published in:
Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00934-x
By:
- Wang, Bo;
- Van Oekelen, Oliver;
- Mouhieddine, Tarek H.;
- Del Valle, Diane Marie;
- Richter, Joshua;
- Cho, Hearn Jay;
- Richard, Shambavi;
- Chari, Ajai;
- Gnjatic, Sacha;
- Merad, Miriam;
- Jagannath, Sundar;
- Parekh, Samir;
- Madduri, Deepu
Publication type:
Article
Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies.
Published in:
Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02616
By:
- Lancman, Guido;
- Arinsburg, Suzanne;
- Jhang, Jeffrey;
- Cho, Hearn Jay;
- Jagannath, Sundar;
- Madduri, Deepu;
- Parekh, Samir;
- Richter, Joshua;
- Chari, Ajai
Publication type:
Article
Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma.
Published in:
2021
By:
- Mouhieddine, Tarek H.;
- Parekh, Samir;
- Cho, Hearn Jay;
- Richter, Joshua;
- DeCastro, Andrew;
- Shah, Jatin;
- Landesman, Yosef;
- Chari, Ajai;
- Jagannath, Sundar;
- Madduri, Deepu
Publication type:
Letter
Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.
Published in:
American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 11, p. 1290, doi. 10.1164/rccm.202108-1859OC
By:
- Criner, Gerard J.;
- Lang, Frederick M.;
- Gottlieb, Robert L.;
- Mathews, Kusum S.;
- Wang, Tisha S.;
- Rice, Todd W.;
- Madduri, Deepu;
- Bellam, Shashi;
- Jeanfreau, Robert;
- Case, Amy H.;
- Glassberg, Marilyn K.;
- Lyon, George Marshall;
- Ahmad, Kareem;
- Mendelson, Robert;
- DiMaio, J. Michael;
- Tran, MaryAnn P.;
- Spak, Cedric W.;
- Abbasi, Jamil A.;
- Davis, Steven G.;
- Ghamande, Shekhar
Publication type:
Article
Anesthetic considerations in the child with Costello syndrome: risks of cardiac arrest upon induction of anesthesia.
Published in:
2008
By:
- Shukry, Mohanad;
- Boucher, Jeremy;
- Madduri, Deepu;
- de Armendi, Alberto J.
Publication type:
Letter
B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies.
Published in:
Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989585
By:
- Sanchez, Larysa;
- Dardac, Alexandra;
- Madduri, Deepu;
- Richard, Shambavi;
- Richter, Joshua
Publication type:
Article
Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma.
Published in:
Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620720987075
By:
- Sanchez, Larysa;
- Richter, Joshua;
- Cho, Hearn Jay;
- Jagannath, Sundar;
- Madduri, Deepu;
- Parekh, Samir;
- Richard, Shambavi;
- Tam, Lowena;
- Verina, Daniel;
- Chari, Ajai
Publication type:
Article
Selinexor in relapsed/refractory multiple myeloma.
Published in:
Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720930629
By:
- Richter, Joshua;
- Madduri, Deepu;
- Richard, Shambavi;
- Chari, Ajai
Publication type:
Article
CAR T-Cell Therapy on the Horizon in Multiple Myeloma.
Published in:
Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 2, p. 54
By:
- Madduri, Deepu
Publication type:
Article
Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 12, p. 882, doi. 10.1016/j.clml.2023.08.012
By:
- Htut, Myo;
- Dhakal, Binod;
- Cohen, Adam D.;
- Martin, Thomas;
- Berdeja, Jesus G.;
- Usmani, Saad Z.;
- Agha, Mounzer;
- Jackson, Carolyn C.;
- Madduri, Deepu;
- Deraedt, William;
- Zudaire, Enrique;
- Yeh, Tzu-min;
- Xu, Xiaoying;
- Pacaud, Lida;
- Akram, Muhammad;
- Jagannath, Sundar
Publication type:
Article
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study.
Published in:
2023
By:
- Cohen, Adam D.;
- Hari, Parameswaran;
- Htut, Myo;
- Berdeja, Jesus G.;
- Usmani, Saad Z.;
- Madduri, Deepu;
- Olyslager, Yunsi;
- Goldberg, Jenna D.;
- Schecter, Jordan M.;
- Jackson, Carolyn C.;
- Gries, Katharine S.;
- Fastenau, John M.;
- Valluri, Satish;
- Deraedt, William;
- Akram, Muhammad;
- Crawford, Rebecca;
- Morrison, Ross;
- Doward, Lynda;
- Morgan, Kate;
- Seldam, Silene ten
Publication type:
journal article
Recent Advances in the Use of Chimeric Antigen Receptor-Expressing T-Cell Therapies for Treatment of Multiple Myeloma.
Published in:
2023
By:
- Martin, Thomas;
- Jackson, Carolyn C.;
- Pacaud, Lida;
- Madduri, Deepu;
- Jagannath, Sundar
Publication type:
journal article
Treatment Bridging With a 28-Day Metronomic Therapy (Metro-28) for Relapsed Refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. 129, doi. 10.1016/j.clml.2021.09.004
By:
- Mouhieddine, Tarek H.;
- Hieulle, Julia;
- Moshier, Erin;
- Richard, Shambavi;
- Richter, Joshua;
- Cho, Hearn Jay;
- Parekh, Samir;
- Barlogie, Bart;
- Chari, Ajai;
- Jagannath, Sundar;
- Madduri, Deepu
Publication type:
Article
Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. e975, doi. 10.1016/j.clml.2021.07.014
By:
- Chari, Ajai;
- Florendo, Erika;
- Mancia, Ines Stefania;
- Cho, Hearn;
- Madduri, Deepu;
- Parekh, Samir;
- Richter, Josh;
- Dhadwal, Amishi;
- Thomas, Joanne;
- Jiang, Grace;
- Lagana, Alessandro;
- Bhalla, Sherry;
- Jagannath, Sundar
Publication type:
Article
P-155: Incidence, mitigation, and management of neurologic adverse events in CARTITUDE-2, a phase 2 study of ciltacabtagene autoleucel (cilta-cel) in patients with Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S120, doi. 10.1016/S2152-2650(21)02282-5
By:
- Einsele, Hermann;
- Parekh, Samir;
- Madduri, Deepu;
- Santomasso, Bianca;
- Pérez-Larraya, Jaime Gállego;
- van de Donk, Niels W.C.J.;
- Arnulf, Bertrand;
- Mateos, María-Victoria;
- De Braganca, Kevin C.;
- Varsos, Helen;
- Carrasco-Alfonso, Marlene J.;
- Akram, Muhammad;
- Lendvai, Nikoletta;
- Jackson, Carolyn C.;
- Olyslager, Yunsi;
- Zudaire, Enrique;
- Li, Claire;
- Dong Geng;
- Jakubowiak, Andrzej;
- Cohen, Adam
Publication type:
Article
P-063: Pathogenic germline variants in hereditary cancer genes in patients with Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S73, doi. 10.1016/S2152-2650(21)02197-2
By:
- Thibaud, Santiago;
- Etra, Aaron;
- Subaran, Ryan;
- Soens, Zachry;
- Newman, Scott;
- Rong Chen;
- Chari, Ajai;
- Cho, Hearn Jay;
- Jagannath, Sundar;
- Madduri, Deepu;
- Melnekoff, David;
- Richard, Shambavi;
- Richter, Joshua;
- Sanchez, Larysa;
- Kuan-Lin Huang;
- Lagana, Alessandro;
- Parekh, Samir;
- Onel, Kenan
Publication type:
Article
OAB-024: Updated results from CARTITUDE-1: Ciltacabtagene autoleucel, a B-cell maturation antigen–directed chimeric antigen receptor T (CAR-T) cell therapy, in relapsed/refractory multiple myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S15, doi. 10.1016/S2152-2650(21)02098-X
By:
- Jagannath, Sundar;
- Berdeja, Jesus G.;
- Jakubowiak, Andrzej;
- Agha, Mounzer;
- Cohen, Adam;
- Madduri, Deepu;
- Hari, Parameswaran;
- Yeh, Tzu-Min;
- Olyslager, Yunsi;
- Banerjee, Arnob;
- Jackson, Carolyn C.;
- Allred, Alicia;
- Zudaire, Enrique;
- Deraedt, William;
- Wu, Xiaoling;
- Pacaud, Lida;
- Akram, Muhammad;
- Lin, Yi;
- Martin, Thomas;
- Usmani, Saad Z.
Publication type:
Article
OAB-023: Efficacy and safety of ciltacabtagene autoleucel, a BCMA-directed CAR-T cell therapy, in patients with progressive multiple myeloma after 1–3 prior lines of therapy: Initial results from CARTITUDE-2.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S15, doi. 10.1016/S2152-2650(21)02097-8
By:
- Cohen, Adam;
- Agha, Mounzer;
- Madduri, Deepu;
- Cohen, Yael;
- Delforge, Michel;
- Hillengass, Jens;
- Goldschmidt, Hartmut;
- Weisel, Katja;
- Raab, Marc-Steffen;
- Scheid, Christoph;
- Schecter, Jordan M.;
- Braganca, Kevin C. De;
- Varsos, Helen;
- Wang, Liwei;
- Vogel, Martin;
- Carrasco-Alfonso, Marlene;
- Akram, Muhammad;
- Wu, Xiaoling;
- Nesheiwat, Tonia;
- Einsele, Hermann
Publication type:
Article
MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S421, doi. 10.1016/S2152-2650(21)01945-5
By:
- Jakubowiak, Andrzej;
- Parekh, Samir;
- Madduri, Deepu;
- Santomasso, Bianca;
- Pérez-Larraya, Jaime Gállego;
- van de Donk, Niels W.C.J.;
- Arnulf, Bertrand;
- Mateos, Maria-Victoria;
- De Braganca, Kevin C.;
- Varsos, Helen;
- Carrasco-Alfonso, Marlene J.;
- Akram, Muhammad;
- Lendvai, Nikoletta;
- Jackson, Carolyn C.;
- Olyslager, Yunsi;
- Zudaire, Enrique;
- Li, Claire;
- Geng, Dong;
- Einsele, Hermann;
- Cohen, Adam
Publication type:
Article
MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S422, doi. 10.1016/S2152-2650(21)01946-7
By:
- Usmani, Saad Z.;
- Berdeja, Jesus G.;
- Madduri, Deepu;
- Jakubowiak, Andrzej;
- Agha, Mounzer;
- Cohen, Adam D.;
- Hari, Parameswaran;
- Yeh, Tzu-Min;
- Olyslager, Yunsi;
- Banerjee, Arnob;
- Jackson, Carolyn C;
- Allred, Alicia;
- Zudaire, Enrique;
- Deraedt, William;
- Wu, Xiaoling;
- Carrasco-Alfonso, Marlene J.;
- Akram, Muhammad;
- Lin, Yi;
- Martin, Thomas;
- Jagannath, Sundar
Publication type:
Article
Poster: MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S249, doi. 10.1016/S2152-2650(21)01569-X
By:
- Usmani, Saad Z.;
- Berdeja, Jesus G.;
- Madduri, Deepu;
- Jakubowiak, Andrzej;
- Agha, Mounzer;
- Cohen, Adam D.;
- Hari, Parameswaran;
- Yeh, Tzu-Min;
- Olyslager, Yunsi;
- Banerjee, Arnob;
- Jackson, Carolyn C;
- Allred, Alicia;
- Zudaire, Enrique;
- Deraedt, William;
- Wu, Xiaoling;
- Carrasco-Alfonso, Marlene J.;
- Akram, Muhammad;
- Lin, Yi;
- Martin, Thomas;
- Jagannath, Sundar
Publication type:
Article
Poster: MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S249, doi. 10.1016/S2152-2650(21)01568-8
By:
- Jakubowiak, Andrzej;
- Parekh, Samir;
- Madduri, Deepu;
- Santomasso, Bianca;
- Pérez-Larraya, Jaime Gállego;
- van de Donk, Niels W.C.J.;
- Arnulf, Bertrand;
- Mateos, Maria-Victoria;
- De Braganca, Kevin C.;
- Varsos, Helen;
- Carrasco-Alfonso, Marlene J.;
- Akram, Muhammad;
- Lendvai, Nikoletta;
- Jackson, Carolyn C.;
- Olyslager, Yunsi;
- Zudaire, Enrique;
- Li, Claire;
- Geng, Dong;
- Einsele, Hermann;
- Cohen, Adam
Publication type:
Article
Oral Abstract: MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S202, doi. 10.1016/S2152-2650(21)01275-1
By:
- Usmani, Saad Z.;
- Berdeja, Jesus G.;
- Madduri, Deepu;
- Jakubowiak, Andrzej;
- Agha, Mounzer;
- Cohen, Adam D.;
- Hari, Parameswaran;
- Yeh, Tzu-Min;
- Olyslager, Yunsi;
- Banerjee, Arnob;
- Jackson, Carolyn C;
- Allred, Alicia;
- Zudaire, Enrique;
- Deraedt, William;
- Wu, Xiaoling;
- Carrasco-Alfonso, Marlene J.;
- Akram, Muhammad;
- Yi Lin;
- Martin, Thomas;
- Jagannath, Sundar
Publication type:
Article
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e470, doi. 10.1016/j.clml.2020.12.026
By:
- Lancman, Guido;
- Lozada, Katleen;
- Athar, Nida;
- Jacobs, Samantha;
- Doucette, John;
- Jay Cho, Hearn;
- Jagannath, Sundar;
- Madduri, Deepu;
- Parekh, Samir;
- Richard, Shambavi;
- Richter, Joshua;
- Chari, Ajai
Publication type:
Article
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies.
Published in:
2020
By:
- Leng, Siyang;
- Moshier, Erin;
- Tremblay, Douglas;
- Hu, Liangyuan;
- Biran, Noa;
- Barman, Naman;
- Parekh, Samir;
- Cho, Hearn;
- Madduri, Deepu;
- Richter, Joshua;
- Barlogie, Bart;
- Jagannath, Sundar;
- Chari, Ajai
Publication type:
journal article
Myeloma CAR-T CRS Management With IL-1R Antagonist Anakinra.
Published in:
2020
By:
- Jatiani, Shashidhar S.;
- Aleman, Adolfo;
- Madduri, Deepu;
- Chari, Ajai;
- Cho, Hearn Jay;
- Richard, Shambavi;
- Richter, Joshua;
- Brody, Joshua;
- Jagannath, Sundar;
- Parekh, Samir
Publication type:
Case Study
SOHO State of the Art Updates and Next Questions: T-Cell-Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor-Modified T Cells and Bispecific T-Cell-Engaging Agents.
Published in:
2019
By:
- Madduri, Deepu;
- Dhodapkar, Madhav V.;
- Lonial, Sagar;
- Jagannath, Sundar;
- Cho, Hearn Jay
Publication type:
journal article
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00629-1
By:
- Cohen, Adam D.;
- Parekh, Samir;
- Santomasso, Bianca D.;
- Pérez-Larraya, Jaime Gállego;
- van de Donk, Niels W. C. J.;
- Arnulf, Bertrand;
- Mateos, Maria-Victoria;
- Lendvai, Nikoletta;
- Jackson, Carolyn C.;
- De Braganca, Kevin C.;
- Schecter, Jordan M.;
- Marquez, Loreta;
- Lee, Erin;
- Cornax, Ingrid;
- Zudaire, Enrique;
- Li, Claire;
- Olyslager, Yunsi;
- Madduri, Deepu;
- Varsos, Helen;
- Pacaud, Lida
Publication type:
Article
Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m<sup>2</sup> in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m<sup>2</sup>.
Published in:
American Journal of Hematology, 2020, v. 95, n. 2, p. E51, doi. 10.1002/ajh.25695
By:
- Barley, Kevin;
- Sanchez, Larysa;
- Cho, Hearn J.;
- Parekh, Samir;
- Madduri, Deepu;
- Richter, Joshua;
- Isola, Luis;
- Goldstein, Talia;
- Dhadwal, Amishi;
- Zarychta, Katarzyna;
- Sanchez, Gillian Morgan;
- Catamero, Donna;
- Verina, Daniel;
- Florendo, Erika;
- Yum, Moon‐hee;
- La, Lisa;
- Gullie, Jude;
- Chan, Elaine;
- Jagannath, Sundar;
- Chari, Ajai
Publication type:
Article
The Effect of Novel Therapies in High-Molecular-Risk Multiple Myeloma.
Published in:
Clinical Advances in Hematology & Oncology, 2017, v. 15, n. 11, p. 870
By:
- Lancman, Guido;
- Tremblay, Douglas;
- Barley, Kevin;
- Barlogie, Bart;
- Cho, Hearn Jay;
- Jagannath, Sundar;
- Madduri, Deepu;
- Moshier, Erin;
- Parekh, Samir;
- Chari, Ajai
Publication type:
Article
Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma.
Published in:
2021
By:
- Martin, Thomas G.;
- Shah, Nina;
- Richter, Joshua;
- Vesole, David H.;
- Wong, Sandy W.;
- Huang, Chiung‐Yu;
- Madduri, Deepu;
- Jagannath, Sundar;
- Siegel, David S.;
- Biran, Noa;
- Wolf, Jeffrey L.;
- Parekh, Samir;
- Cho, Hearn J.;
- Munster, Pamela;
- Richard, Shambavi;
- Ziti‐Ljajic, Samira;
- Chari, Ajai;
- Huang, Chiung-Yu;
- Ziti-Ljajic, Samira
Publication type:
journal article

Found: 31